These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


677 related items for PubMed ID: 15840033

  • 1. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
    Kazama I, Hatano R, Michimata M, Suzuki K, Arata T, Suzuki M, Miyama N, Sato A, Satomi S, Ejima Y, Sasaki S, Matsubara M.
    Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
    [Abstract] [Full Text] [Related]

  • 2. Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
    Kazama I, Arata T, Michimata M, Hatano R, Suzuki M, Miyama N, Sanada S, Sato A, Satomi S, Ejima Y, Sasaki S, Matsubara M.
    Nephrol Dial Transplant; 2007 Jan; 22(1):68-76. PubMed ID: 16702208
    [Abstract] [Full Text] [Related]

  • 3. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
    Saito T, Higashiyama M, Nagasaka S, Sasaki S, Saito T, Ishikawa SE.
    Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
    [Abstract] [Full Text] [Related]

  • 4. Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy.
    Michimata M, Fujita S, Araki T, Mizukami K, Kazama I, Muramatsu Y, Suzuki M, Kimura T, Sasaki S, Imai Y, Matsubara M.
    Kidney Int; 2003 Jan; 63(1):165-71. PubMed ID: 12472779
    [Abstract] [Full Text] [Related]

  • 5. Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla.
    Kortenoeven ML, Sinke AP, Hadrup N, Trimpert C, Wetzels JF, Fenton RA, Deen PM.
    Am J Physiol Renal Physiol; 2013 Dec 15; 305(12):F1705-18. PubMed ID: 24154696
    [Abstract] [Full Text] [Related]

  • 6. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Wada K, Matsukawa U, Fujimori A, Arai Y, Sudoh K, Sasamata M, Miyata K.
    Biol Pharm Bull; 2007 Jan 15; 30(1):91-5. PubMed ID: 17202666
    [Abstract] [Full Text] [Related]

  • 7. Pathological role of aquaporin-2 in impaired water excretion and hyponatremia.
    Ishikawa S, Saito T, Kasono K.
    J Neuroendocrinol; 2004 Apr 15; 16(4):293-6. PubMed ID: 15089964
    [Abstract] [Full Text] [Related]

  • 8. Vasopressin-independent renal urinary concentration: increased rBSC1 and enhanced countercurrent multiplication.
    Michimata M, Mizukami K, Suzuki M, Kazama I, Nakamura Y, Suzuki K, Yanagisawa T, Imai Y, Sasaki S, Matsubara M.
    Kidney Int; 2003 Sep 15; 64(3):933-8. PubMed ID: 12911543
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats.
    Kwon TH, Nielsen J, Knepper MA, Frøkiaer J, Nielsen S.
    Am J Physiol Renal Physiol; 2005 Apr 15; 288(4):F673-84. PubMed ID: 15585668
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Saito T, Ishikawa S, Abe K, Kamoi K, Yamada K, Shimizu K, Saruta T, Yoshida S.
    J Clin Endocrinol Metab; 1997 Apr 15; 82(4):1054-7. PubMed ID: 9100572
    [Abstract] [Full Text] [Related]

  • 12. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G.
    J Lab Clin Med; 2001 Jul 15; 138(1):18-21. PubMed ID: 11433224
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats.
    Fujisawa G, Ishikawa S, Tsuboi Y, Okada K, Saito T.
    Kidney Int; 1993 Jul 15; 44(1):19-23. PubMed ID: 8355461
    [Abstract] [Full Text] [Related]

  • 14. Vasopressin escape and memory impairment in a model of chronic syndrome of inappropriate secretion of antidiuretic hormone in mice.
    Kawakami T, Fujisawa H, Nakayama S, Yoshino Y, Hattori S, Seino Y, Takayanagi T, Miyakawa T, Suzuki A, Sugimura Y.
    Endocr J; 2021 Jan 28; 68(1):31-43. PubMed ID: 32879162
    [Abstract] [Full Text] [Related]

  • 15. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects.
    Ishikawa Se, Saito T, Fukagawa A, Higashiyama M, Nakamura T, Kusaka I, Nagasaka S, Honda K, Saito T.
    J Clin Endocrinol Metab; 2001 Apr 28; 86(4):1665-71. PubMed ID: 11297601
    [Abstract] [Full Text] [Related]

  • 16. Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats.
    Fujita N, Ishikawa SE, Sasaki S, Fujisawa G, Fushimi K, Marumo F, Saito T.
    Am J Physiol; 1995 Dec 28; 269(6 Pt 2):F926-31. PubMed ID: 8594889
    [Abstract] [Full Text] [Related]

  • 17. Single-tubule RNA-Seq uncovers signaling mechanisms that defend against hyponatremia in SIADH.
    Lee JW, Alsady M, Chou CL, de Groot T, Deen PMT, Knepper MA, Ecelbarger CM.
    Kidney Int; 2018 Jan 28; 93(1):128-146. PubMed ID: 28843412
    [Abstract] [Full Text] [Related]

  • 18. Studies of renal aquaporin-2 expression during renal escape from vasopressin-induced antidiuresis.
    Verbalis JG, Murase T, Ecelbarger CA, Nielsen S, Knepper MA.
    Adv Exp Med Biol; 1998 Jan 28; 449():395-406. PubMed ID: 10026831
    [Abstract] [Full Text] [Related]

  • 19. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis.
    Tian Y, Sandberg K, Murase T, Baker EA, Speth RC, Verbalis JG.
    Endocrinology; 2000 Jan 28; 141(1):307-14. PubMed ID: 10614652
    [Abstract] [Full Text] [Related]

  • 20. Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260.
    Kamoi K.
    Nephron; 1997 Jan 28; 76(1):111-5. PubMed ID: 9171309
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.